Penn State College of Medicine pilot study suggests a low dose of naltrexone, a drug used to ease symptoms of alcohol and drug addiction, may also bring relief to people with Crohn's disease, a chronic inflammatory disorder of the intestine that affects an estimated 500,000 Americans. The study resu...
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
ShaRe International Foundation has released details on www.sharktank.org that describes their radically new therapy to alleviate the symptoms of cystic fibrosis. Cystic Fibrosis affects the respiratory and digestive systems. One in 30 people are carriers of the CF gene and one in 2500 babies are bor...
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
Cystic fibrosis (CF) is caused by mutations in a gene that encodes a protein known as CFTR. More than 1000 different disease-causing mutations in CFTR have been identified, and although the overall effect of each mutation is to decrease CFTR expression at the cell surface, it is not known for every ...
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
Surgeon Dr. Fabrizio Michelassi's "side-to-side isoperistaltic stricturoplasty" procedure can alleviate the pain of Crohn's disease while sparing the intestine and safeguarding patients from developing malnutrition. The procedure is a welcome alternative to traditional methods which rely on removing...
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
Georgetown University Medical Center researchers today published the first ever fMRI study of hyperlexia, a rare condition in which children with some degree of autism display extremely precocious reading skills. Appearing in Neuron, the case study uncovers the neural mechanisms that underlie hyperl...
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
Learning disabilities such as dyslexia are believed to affect nearly one in 10 children. To better study them, a Northwestern University research team has developed a data-driven conceptual framework that links two well-established scientific concepts. In doing so, they also have developed a non-inv...
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
Fistulas are common in Crohn's disease and occur in the perianal region or are internal, between intestinal structures or between the intestine and other organs such as the bladder or the abdominal wall. This article, published in the journal "Digestion", presents treatments and their outcome.Medica...
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
Researchers trying to tease out the genetic basis of dyslexia have discovered a location on chromosome 2 that may contain one or more genes that contribute to the reading disorder and make it difficult for people to rapidly pronounce pseudowords. The team from the University of Washington, headed by...
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
UCB today announced the submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMEA) for the approval of CIMZIATM (certolizumab pegol, CDP870) in the treatment of patients with Crohn's disease. When approved, CIMZIA(TM) will represent the first and only biologic ...
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
Medinews is an online community dedicated for promoting and discussing latest medical news, research articles and blogs. You can also find regular updates on health news for discussion by health professionals.
